<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">In this study, we determined the presence and extent of shared genetic etiology between PD and the blood levels of 370 lipids and lipid-related molecules. In phase I, we detected genetic overlap (at least one 
 <italic>P</italic>
 <sub>T</sub> showing statistical significance after Bonferroni correction, i.e., 
 <italic>P</italic> &lt; 1.93E-05) between PD and the plasma levels of 25 lipids (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). A complete overview of the results of all PRS-based analyses is shown in Supplementary Data 
 <xref rid="MOESM3" ref-type="media">1</xref>. Of note, we found prominent genetic sharing between PD and the blood levels of six specific lipids (MAG 18:1, PUFA 20:5n3, AC 14:2, LPC 17:0, LPC 18:0, and SM 26:0) as each of these lipids showed significance—after Bonferroni correction—at all 
 <italic>P</italic>
 <sub>T</sub>s, except for the lowest one (
 <italic>P</italic>
 <sub>T</sub> = 0.001) (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>). Further, genetic variants associated with PD explain at least 1% of the variation in blood levels of six lipids, i.e., the aforementioned AC 14:2, LPC 18:0, and SM 26:0, as well as TAG 44:1, TAG 46:2, and CE 20:5 (Figs. 
 <xref rid="Fig1" ref-type="fig">1</xref> and 
 <xref rid="Fig2" ref-type="fig">2</xref>).
</p>
